219 related articles for article (PubMed ID: 33323968)
1. Regucalcin promotes dormancy of prostate cancer.
Sharma S; Pei X; Xing F; Wu SY; Wu K; Tyagi A; Zhao D; Deshpande R; Ruiz MG; Singh R; Lyu F; Watabe K
Oncogene; 2021 Feb; 40(5):1012-1026. PubMed ID: 33323968
[TBL] [Abstract][Full Text] [Related]
2. Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells.
Vaz CV; Rodrigues DB; Socorro S; Maia CJ
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2621-8. PubMed ID: 26171977
[TBL] [Abstract][Full Text] [Related]
3. Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways.
Vaz CV; Maia CJ; Marques R; Gomes IM; Correia S; Alves MG; Cavaco JE; Oliveira PF; Socorro S
Prostate; 2014 Sep; 74(12):1189-98. PubMed ID: 24975685
[TBL] [Abstract][Full Text] [Related]
4. Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation.
Vaz CV; Marques R; Cardoso HJ; Maia CJ; Socorro S
Transgenic Res; 2016 Apr; 25(2):139-48. PubMed ID: 26553531
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract][Full Text] [Related]
6. microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1.
Yang B; Diao H; Wang P; Guan F; Liu H
Bioengineered; 2021 Dec; 12(1):9094-9102. PubMed ID: 34654353
[TBL] [Abstract][Full Text] [Related]
7. Aging-associated changes in oxidative stress, cell proliferation, and apoptosis are prevented in the prostate of transgenic rats overexpressing regucalcin.
Vaz CV; Marques R; Maia CJ; Socorro S
Transl Res; 2015 Dec; 166(6):693-705. PubMed ID: 26397424
[TBL] [Abstract][Full Text] [Related]
8. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
[TBL] [Abstract][Full Text] [Related]
9. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis.
Marques R; Vaz CV; Maia CJ; Gomes M; Gama A; Alves G; Santos CR; Schmitt F; Socorro S
Exp Cell Res; 2015 Jan; 330(2):325-335. PubMed ID: 25128811
[TBL] [Abstract][Full Text] [Related]
11. TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression.
Mashima T; Soma-Nagae T; Migita T; Kinoshita R; Iwamoto A; Yuasa T; Yonese J; Ishikawa Y; Seimiya H
Cancer Res; 2014 Sep; 74(17):4888-97. PubMed ID: 24962028
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
13. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
[No Abstract] [Full Text] [Related]
14. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
Pan H; Zhu Y; Wei W; Shao S; Rui X
World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views.
Vaz CV; Correia S; Cardoso HJ; Figueira MI; Marques R; Maia CJ; Socorro S
Curr Mol Med; 2016; 16(7):607-619. PubMed ID: 27411833
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
[TBL] [Abstract][Full Text] [Related]
19. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
Wang W; Guo Z; Yu H; Fan L
J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
[TBL] [Abstract][Full Text] [Related]
20. Transgenic overexpression of regucalcin leads to suppression of thapsigargin- and actinomycin D-induced apoptosis in the testis by modulation of apoptotic pathways.
Correia S; Alves MG; Oliveira PF; Alves MR; van Pelt AM; Cavaco JE; Socorro S
Andrology; 2014 Mar; 2(2):290-8. PubMed ID: 24519986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
